These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 21041611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Ketamine for treatment of acute depression].
    Hjerrild S, Bjerre J, Pedersen RH, Videbech P.
    Ugeskr Laeger; 2013 Sep 09; 175(37):2090-3. PubMed ID: 24011203
    [Abstract] [Full Text] [Related]

  • 3. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS, Grant JS, Keltner NL.
    Perspect Psychiatr Care; 2013 Jan 09; 49(1):2-4. PubMed ID: 23293991
    [No Abstract] [Full Text] [Related]

  • 4. Ketamine and the potential role for rapid-acting antidepressant medications.
    Krystal JH.
    Swiss Med Wkly; 2007 Apr 21; 137(15-16):215-6. PubMed ID: 17525875
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of action of ketamine.
    Stahl SM.
    CNS Spectr; 2013 Aug 21; 18(4):171-4. PubMed ID: 23866089
    [Abstract] [Full Text] [Related]

  • 6. Blocking NMDA receptor at rest: a possible alleviation of depression.
    Lu W.
    Acta Pharmacol Sin; 2011 Sep 21; 32(9):1087-8. PubMed ID: 21804573
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ketamine and phencyclidine: the good, the bad and the unexpected.
    Lodge D, Mercier MS.
    Br J Pharmacol; 2015 Sep 21; 172(17):4254-76. PubMed ID: 26075331
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ketamine for Treatment-Resistant Depression: a New Advocate.
    Pérez-Esparza R.
    Rev Invest Clin; 2018 Sep 21; 70(2):65-7. PubMed ID: 29718013
    [Abstract] [Full Text] [Related]

  • 14. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA.
    J Psychopharmacol; 2007 May 21; 21(3):259-71. PubMed ID: 17591654
    [Abstract] [Full Text] [Related]

  • 15. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.
    Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, Correll CU.
    Psychol Med; 2016 May 21; 46(7):1459-72. PubMed ID: 26867988
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroscience. A glutamate pathway to faster-acting antidepressants?
    Cryan JF, O'Leary OF.
    Science; 2010 Aug 20; 329(5994):913-4. PubMed ID: 20724626
    [No Abstract] [Full Text] [Related]

  • 19. Glutamate-based antidepressants: 20 years on.
    Skolnick P, Popik P, Trullas R.
    Trends Pharmacol Sci; 2009 Nov 20; 30(11):563-9. PubMed ID: 19837463
    [Abstract] [Full Text] [Related]

  • 20. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R, Markovic K, Thürauf N, Schmitt H, Kornhuber J.
    Aust N Z J Psychiatry; 2008 Feb 20; 42(2):170. PubMed ID: 18197514
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.